“Heptovax” - Ensayo de fase II, abierto, para evaluar la seguridad y la eficacia de GV1001 para el carcinoma hepatocelular avanzado. (CHC) Investigar la eficacia de GV1001 en el CHC localmente avanzado o metastásico.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

“Primovax” – A Phase III Trial Comparing GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Advanced Un-resectable Pancreatic Cancer To investigate the efficacy of GV1001 in sequential combination with gemcitabine in locally advanced or metastatic adenocarcinoma of the pancreas.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Phase II trial evaluating the immunological and clinical efficay and safety of HER-2 Protein Autovac(TM) monotherapy in patients with metastatic breast cancer The primary objective of the trial is to demonstrate evidence of clinical efficacy of HER-2 Protein AutoVac(TM), that is the number of evaluable patients with evidence of clinical benefit, defined as:...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Phase II trial evaluating the immunological and clinical efficacy and safety of HER-2 Protein AutoVac(TM) and Stimulon® Adjuvant QS-21 monotherapy in patients with metastatic breast cancer The primary objective of the trial is to demonstrate evidence of clinical efficacy of HER-2 Protein AutoVac(TM)/QS-21, that is the number of evaluable patients with evidence of clinical benefit, defin...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune